Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exercise | 14 | 2022 | 672 | 1.850 |
Why?
|
| Exercise Therapy | 7 | 2022 | 270 | 1.800 |
Why?
|
| Mobility Limitation | 10 | 2019 | 219 | 1.740 |
Why?
|
| Health Education | 10 | 2019 | 157 | 1.140 |
Why?
|
| Adipose Tissue | 3 | 2016 | 347 | 1.000 |
Why?
|
| Aged | 35 | 2023 | 10340 | 0.850 |
Why?
|
| Health Promotion | 3 | 2015 | 246 | 0.820 |
Why?
|
| Aged, 80 and over | 25 | 2018 | 4000 | 0.740 |
Why?
|
| Muscle Strength | 5 | 2023 | 161 | 0.740 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 494 | 0.690 |
Why?
|
| Obesity | 5 | 2016 | 1179 | 0.670 |
Why?
|
| Muscles | 2 | 2023 | 62 | 0.640 |
Why?
|
| Aging | 6 | 2017 | 945 | 0.610 |
Why?
|
| Female | 36 | 2022 | 19954 | 0.600 |
Why?
|
| Motor Activity | 4 | 2015 | 325 | 0.580 |
Why?
|
| Male | 33 | 2022 | 19196 | 0.580 |
Why?
|
| Risk Reduction Behavior | 3 | 2017 | 125 | 0.570 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 518 | 0.570 |
Why?
|
| Accidental Falls | 4 | 2016 | 221 | 0.540 |
Why?
|
| Disabled Persons | 5 | 2018 | 105 | 0.530 |
Why?
|
| Aspirin | 4 | 2022 | 64 | 0.520 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 140 | 0.520 |
Why?
|
| Geriatric Assessment | 7 | 2018 | 391 | 0.520 |
Why?
|
| Humans | 40 | 2023 | 32025 | 0.510 |
Why?
|
| Executive Function | 1 | 2015 | 57 | 0.510 |
Why?
|
| Dietary Supplements | 2 | 2023 | 188 | 0.510 |
Why?
|
| Walking | 6 | 2019 | 210 | 0.490 |
Why?
|
| Body Mass Index | 5 | 2016 | 923 | 0.490 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2018 | 83 | 0.460 |
Why?
|
| Dementia | 2 | 2018 | 252 | 0.450 |
Why?
|
| Disability Evaluation | 4 | 2018 | 240 | 0.450 |
Why?
|
| Insulin Resistance | 1 | 2016 | 461 | 0.420 |
Why?
|
| Vitamin D Deficiency | 1 | 2023 | 89 | 0.410 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 1125 | 0.400 |
Why?
|
| African Americans | 2 | 2016 | 1428 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2017 | 1428 | 0.370 |
Why?
|
| Single-Blind Method | 8 | 2018 | 203 | 0.350 |
Why?
|
| Oxygen Consumption | 3 | 2015 | 154 | 0.310 |
Why?
|
| Actigraphy | 1 | 2017 | 13 | 0.310 |
Why?
|
| Frail Elderly | 1 | 2018 | 69 | 0.290 |
Why?
|
| Hand Strength | 2 | 2015 | 101 | 0.290 |
Why?
|
| Life Style | 5 | 2022 | 408 | 0.290 |
Why?
|
| Lower Extremity | 2 | 2016 | 100 | 0.290 |
Why?
|
| Diet, Reducing | 2 | 2009 | 106 | 0.280 |
Why?
|
| United States | 11 | 2018 | 3938 | 0.270 |
Why?
|
| Mitochondria, Muscle | 1 | 2015 | 18 | 0.250 |
Why?
|
| Food Services | 2 | 2015 | 20 | 0.250 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 95 | 0.240 |
Why?
|
| Risk Factors | 8 | 2022 | 3869 | 0.240 |
Why?
|
| Age Factors | 4 | 2017 | 1194 | 0.240 |
Why?
|
| Cholecalciferol | 2 | 2023 | 20 | 0.240 |
Why?
|
| Minority Health | 1 | 2014 | 8 | 0.240 |
Why?
|
| Religion and Medicine | 1 | 2014 | 19 | 0.230 |
Why?
|
| Vitamins | 2 | 2023 | 68 | 0.230 |
Why?
|
| Weight Loss | 2 | 2009 | 480 | 0.230 |
Why?
|
| Hemorrhage | 3 | 2018 | 100 | 0.230 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2014 | 87 | 0.210 |
Why?
|
| Geriatrics | 2 | 2014 | 85 | 0.210 |
Why?
|
| Health Behavior | 1 | 2014 | 231 | 0.200 |
Why?
|
| Primary Health Care | 1 | 2014 | 227 | 0.200 |
Why?
|
| Cognition | 2 | 2017 | 553 | 0.200 |
Why?
|
| Resistance Training | 2 | 2016 | 82 | 0.190 |
Why?
|
| Postmenopause | 2 | 2010 | 414 | 0.190 |
Why?
|
| Cross-Sectional Studies | 4 | 2016 | 1530 | 0.190 |
Why?
|
| Mortality | 2 | 2018 | 125 | 0.190 |
Why?
|
| Adipokines | 1 | 2010 | 16 | 0.180 |
Why?
|
| Muscle Weakness | 1 | 2010 | 37 | 0.180 |
Why?
|
| Glucose Tolerance Test | 2 | 2016 | 125 | 0.170 |
Why?
|
| Australia | 4 | 2022 | 72 | 0.170 |
Why?
|
| Double-Blind Method | 3 | 2023 | 526 | 0.170 |
Why?
|
| Body Composition | 2 | 2009 | 396 | 0.170 |
Why?
|
| Fatigue | 1 | 2019 | 85 | 0.170 |
Why?
|
| Independent Living | 4 | 2018 | 99 | 0.170 |
Why?
|
| Middle Aged | 6 | 2016 | 11868 | 0.160 |
Why?
|
| Abdominal Fat | 1 | 2009 | 50 | 0.160 |
Why?
|
| Risk Assessment | 3 | 2015 | 1435 | 0.160 |
Why?
|
| Kidney | 1 | 2022 | 515 | 0.150 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 319 | 0.150 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 28 | 0.150 |
Why?
|
| Adolescent | 2 | 2016 | 3526 | 0.150 |
Why?
|
| Environment Design | 1 | 2016 | 18 | 0.140 |
Why?
|
| Time Factors | 3 | 2017 | 2152 | 0.140 |
Why?
|
| Treatment Outcome | 3 | 2018 | 3317 | 0.140 |
Why?
|
| Muscle Stretching Exercises | 1 | 2015 | 6 | 0.130 |
Why?
|
| Adult | 3 | 2016 | 9367 | 0.130 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 193 | 0.130 |
Why?
|
| Homebound Persons | 1 | 2015 | 9 | 0.130 |
Why?
|
| Adipocytes | 1 | 2006 | 80 | 0.130 |
Why?
|
| Vitamin D | 2 | 2023 | 183 | 0.130 |
Why?
|
| Health Status | 1 | 2008 | 399 | 0.130 |
Why?
|
| Residence Characteristics | 1 | 2016 | 191 | 0.130 |
Why?
|
| Ankle Brachial Index | 1 | 2015 | 39 | 0.120 |
Why?
|
| Upper Extremity | 1 | 2015 | 57 | 0.120 |
Why?
|
| Motor Skills Disorders | 1 | 2014 | 7 | 0.120 |
Why?
|
| Quality of Life | 3 | 2018 | 933 | 0.120 |
Why?
|
| Heart Rate | 1 | 2016 | 334 | 0.120 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 35 | 0.120 |
Why?
|
| Forced Expiratory Volume | 1 | 2014 | 97 | 0.120 |
Why?
|
| Treatment Failure | 3 | 2018 | 163 | 0.120 |
Why?
|
| Administration, Oral | 3 | 2018 | 182 | 0.120 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 549 | 0.110 |
Why?
|
| Models, Educational | 1 | 2013 | 20 | 0.110 |
Why?
|
| Hospitalization | 1 | 2016 | 470 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 835 | 0.110 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2013 | 58 | 0.100 |
Why?
|
| European Continental Ancestry Group | 1 | 2016 | 1169 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2015 | 544 | 0.100 |
Why?
|
| Gait | 3 | 2017 | 141 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 507 | 0.090 |
Why?
|
| Incidence | 2 | 2018 | 1200 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2013 | 384 | 0.090 |
Why?
|
| Postural Balance | 2 | 2016 | 182 | 0.080 |
Why?
|
| Prognosis | 2 | 2017 | 1505 | 0.080 |
Why?
|
| Young Adult | 1 | 2016 | 2615 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2018 | 186 | 0.080 |
Why?
|
| Waist Circumference | 1 | 2016 | 90 | 0.070 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 33 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 271 | 0.060 |
Why?
|
| North Carolina | 2 | 2014 | 1516 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 878 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2016 | 224 | 0.060 |
Why?
|
| Organizational Case Studies | 1 | 2014 | 11 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 353 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 268 | 0.060 |
Why?
|
| Home Care Services | 1 | 2014 | 51 | 0.060 |
Why?
|
| Health Surveys | 1 | 2014 | 197 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2013 | 195 | 0.050 |
Why?
|
| Educational Measurement | 2 | 2014 | 123 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 2280 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2013 | 166 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2016 | 845 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2014 | 333 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 211 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2009 | 91 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2010 | 253 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 76 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2009 | 106 | 0.040 |
Why?
|
| Cause of Death | 1 | 2018 | 238 | 0.040 |
Why?
|
| Self Efficacy | 1 | 2008 | 78 | 0.040 |
Why?
|
| Leisure Activities | 1 | 2016 | 13 | 0.040 |
Why?
|
| Pulse | 1 | 2016 | 10 | 0.040 |
Why?
|
| Overweight | 1 | 2009 | 279 | 0.040 |
Why?
|
| Rest | 1 | 2016 | 54 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2009 | 492 | 0.030 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2006 | 15 | 0.030 |
Why?
|
| Cell Size | 1 | 2006 | 38 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 371 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 259 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 420 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 292 | 0.030 |
Why?
|
| Spirometry | 1 | 2014 | 30 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 565 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 2283 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 663 | 0.030 |
Why?
|
| Risk | 1 | 2014 | 319 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 464 | 0.030 |
Why?
|
| Neoplasms | 1 | 2018 | 692 | 0.020 |
Why?
|
| Curriculum | 1 | 2013 | 213 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 1831 | 0.020 |
Why?
|